Scribd Logo
Upload

Welcome to Scribd!

  • Drug Study - Metoclopramide

    Uploaded by

    Izza Deloria
    49 views3 pages
    Metoclopramide is a GI stimulant brand named Metonia. It works by stimulating motility in the upper GI tract, increasing lower esophageal sphincter tone, and blocking dopamine receptors. It is used to treat symptoms of acute and recurrent diabetic gastroparesis and GERD. Nurses should monitor for potential side effects like dizziness, headache, nervousness, and extrapyramidal symptoms as well as instruct patients on proper use and signs of adverse reactions.

    Original Description:

    Original Title

    drug study - metoclopramide

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Metoclopramide is a GI stimulant brand named Metonia. It works by stimulating motility in the upper GI tract, increasing lower esophageal sphincter tone, and blocking dopamine receptors. It is used to treat symptoms of acute and recurrent diabetic gastroparesis and GERD. Nurses should monitor for potential side effects like dizziness, headache, nervousness, and extrapyramidal symptoms as well as instruct patients on proper use and signs of adverse reactions.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    49 views3 pages

    Drug Study - Metoclopramide

    Uploaded by

    Izza Deloria
    Metoclopramide is a GI stimulant brand named Metonia. It works by stimulating motility in the upper GI tract, increasing lower esophageal sphincter tone, and blocking dopamine receptors. It is used to treat symptoms of acute and recurrent diabetic gastroparesis and GERD. Nurses should monitor for potential side effects like dizziness, headache, nervousness, and extrapyramidal symptoms as well as instruct patients on proper use and signs of adverse reactions.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    of 3

    GENERIC NAME metoclopramide

    BRAND NAME Metonia

    CLASSIFICATION GI stimulant

    DOSAGE AND FREQUENCY 10mg, IVTT q8

    MECHANISM OF ACTION Stimulates motility of upper GI tract, increases

    lower esophageal sphincter tone, and blocks

    dopamine receptors at the chemoreceptor

    trigger zone

    INDICATIONS Relief symptoms of acute and recurrent

    diabetic gastroparesis, short-term therapy for

    adults with symptomatic GERD who fail to

    responds to conventional therapy

    CONTRAINDICATIONS hypersensitivity; use cautiously in patient with

    history of depression, Parkinson’s disease or

    HTN

    SIDE EFFECTS nervousness, dizziness, restlessness, confusion,

    trouble sleeping
    ADVERSE EFFECTS CNS: anxiety, drowsiness, dystonic reaction,

    fatigue, restlessness, seizure, fever,

    hallucination, headache, insomnia, dizziness

    CV: bradycardia, supraventricular tachycardia,

    hypotension, transient HTN, HF

    GI: bowel disorder, diarrhea, nausea

    GU: incontinence, urinary frequency, erectile

    dysfunction

    Hematologic: agranulocytosis, neutropenia

    Skin: rash, urticaria

    NURSING RESPONSIBILITIES 1. Monitor the bowel sounds of the patient

    2. Monitor patient for dizziness, headache,

    or nervousness after the drug is

    stopped; these may indicate withdrawal

    3. Monitor patient for fever, CNS

    symptoms, irregular pulse, cardiac

    arrhythmias or abnormal BP which may

    indicate NMS

    4. Tell patient to avoid activities that

    require alertness for 2 hours after doses

    5. Tell patient to report persistent or

    serious adverse reaction promptly


    6. Teach patient signs and symptoms of

    tardive dyskinesia, other

    extrapyramidal signs and symptoms

    and NMS

    7. Advise patient to discontinue drug and

    to seek immediate medical attention if

    sign and symptoms of tardive

    dyskinesia occur

    8. Advise patient not to drink alcohol after

    therapy

    9. Monitor for possible hypernatremia and

    hypokalemia, especially if patient has

    CHF or cirrhosis

    10. Report immediately the onset of

    restlessness, involuntary movements,

    facial grimacing and tremors.

    You might also like